Serum levels of leptin and homocysteine in women with polycystic ovary syndrome and its relationship to endocrine, clinical and metabolic parameters

被引:31
作者
Atamer, A. [1 ]
Demir, B. [1 ]
Bayhan, G. [2 ]
Atamer, Y. [3 ]
Ilhan, N. [4 ]
Akkus, Z. [5 ]
机构
[1] Ergani State Hosp, Dept Obstet & Gynaecol, Diyarbakir, Turkey
[2] Suleyman Demirel Univ, Fac Med, Dept Obstet & Gynaecol, Isparta, Turkey
[3] Dicle Univ, Fac Med, Dept Clin Biochem, Diyarbakir, Turkey
[4] Firat Univ, Fac Med, Dept Clin Biochem, Elazig, Turkey
[5] Dicle Univ, Fac Med, Dept Biostat, Diyarbakir, Turkey
关键词
polycystic ovary-syndrome; insulin resistance; insulin-like growth factors; sex steroids; lipid metabolites; leptin; homocysteine;
D O I
10.1177/147323000803600113
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We examined the relationship between endocrine, clinical and metabolic parameters in 35 women (mean age 27.3 years) with polycystic ovary syndrome (PCOS) and 30 age- and body mass index-matched normal ovulatory women. In PCOS women, serum leptin, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3 levels and the insulin resistance index (HOMA-IR) were significantly higher, while sex hormone-binding globulin and high-density lipoprotein cholesterol levels were lower compared with healthy women. Serum luteinizing hormone (LH), estradiol (E-2), androstenedione, testosterone and dehydroepiandrosterone sulphate levels were found to be significantly higher in PCOS women compared with healthy women. The levels of E-2, LH and testosterone were positively correlated with leptin levels in PCOS women. Similarly, androstenedione levels and HOMA-IR were positively correlated with homocysteine levels and insulin levels were positively correlated with LH. We conclude that increased homocysteine levels, hyperandrogenaemia, insulin resistance and impaired lipid metabolism contribute to the risk of premature atherosclerosis in PCOS women.
引用
收藏
页码:96 / 105
页数:10
相关论文
共 31 条
[1]   Insulin, androgens, and obesity in women with and without polycystic ovary syndrome:: a heterogeneous group of disorders [J].
Acién, P ;
Quereda, F ;
Matallín, P ;
Villarroya, E ;
López-Fernández, JA ;
Acién, M ;
Mauri, M ;
Alfayate, R .
FERTILITY AND STERILITY, 1999, 72 (01) :32-40
[2]  
ADASHI EY, 1993, ANN NY ACAD SCI, V687, P10
[3]   Plasma homocysteine and polycystic ovary syndrome: The missed link [J].
Badawy, Ahmed ;
State, Omnia ;
El Gawad, Soma Sh. Abd ;
El Aziz, Omar Abd .
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 131 (01) :68-72
[4]   Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome [J].
Belli, SH ;
Graffigna, MN ;
Oneto, A ;
Otero, P ;
Schurman, L ;
Levalle, OA .
FERTILITY AND STERILITY, 2004, 81 (03) :624-629
[5]   INSULIN-LIKE GROWTH FACTOR-I AND INSULIN POTENTIATE LUTEINIZING HORMONE-INDUCED ANDROGEN SYNTHESIS BY RAT OVARIAN THECAL-INTERSTITIAL CELLS [J].
CARA, JF ;
ROSENFIELD, RL .
ENDOCRINOLOGY, 1988, 123 (02) :733-739
[6]   Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome [J].
Cattrall, FR ;
Healy, DL .
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (05) :803-812
[7]   Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome? [J].
Erel, CT ;
Senturk, LM ;
Kaleli, S ;
Gezer, A ;
Baysal, B ;
Tasan, E .
GYNECOLOGICAL ENDOCRINOLOGY, 2003, 17 (03) :223-229
[8]   INSULIN-LIKE GROWTH FACTOR-I REGULATES AROMATASE-ACTIVITY IN HUMAN GRANULOSA AND GRANULOSA LUTEAL CELLS [J].
ERICKSON, GF ;
GARZO, VG ;
MAGOFFIN, DA .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 69 (04) :716-724
[9]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].
Fauser, BCJM ;
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
HUMAN REPRODUCTION, 2004, 19 (01) :41-47
[10]   Metformin-diet benefits in women with polycystic ovary syndrome in the bottom and top quintiles for insulin resistance [J].
Goldenberg, N ;
Glueck, CJ ;
Loftspring, M ;
Sherman, A ;
Wang, P .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (01) :113-121